Narcan rapidly reverses the effects of opioid overdose and remains the standard treatment for such an overdose. Approval allows direct-to-consumer sales in places like drug stores, convenience stores and more. The FDA nod comes about six weeks after an agency committee voted unanimously in favor of OTC use.
This marks the first approval for a naloxone product for use without a prescription. Emergent BioSolutions received the approval.
Get the full story at our sister site, Drug Delivery Business News.